Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [9532]
News [23415]
Articles [1991]
Editorials [134]
Conferences [465]
elearning [298]
Carfilzomib represents potent, effective addition to standard multiple myeloma...
Prof Keith Stewart - Mayo Clinic, Scottsdale, USA
Carfilzomib represents potent, effective addition to standard multiple myeloma therapy in phase III study ( Prof Keith Stewart - Mayo Clinic, Scottsdale, USA )
7 Dec 2014
Post-transplant survival boosted by brentuximab vedotin in lymphoma
Dr Craig Moskowitz - Memorial Sloan Kettering Cancer Center, New York, USA
Post-transplant survival boosted by brentuximab vedotin in lymphoma ( Dr Craig Moskowitz - Memorial Sloan Kettering Cancer Center, New York, USA )
7 Dec 2014
Brentuximab vedotin prolongs post-transplant survival in hard-to-treat lymphoma...
Dr Craig Moskowitz - Memorial Sloan Kettering Cancer Center, New York, USA
Brentuximab vedotin prolongs post-transplant survival in hard-to-treat lymphoma patients in phase III study ( Dr Craig Moskowitz - Memorial Sloan Kettering Cancer Center, New York, USA )
7 Dec 2014
Children with aggressive leukaemia experiencing remission with T cell therapy
Dr Stephan Grupp - The Children's Hospital of Philadelphia, Philadelphia, USA
Children with aggressive leukaemia experiencing remission with T cell therapy ( Dr Stephan Grupp - The Children's Hospital of Philadelphia, Philadelphia, USA )
7 Dec 2014
ASPIRE study: Carfilzomib potent addition to multiple myeloma therapy
Prof Keith Stewart - Mayo Clinic, Scottsdale, USA
ASPIRE study: Carfilzomib potent addition to multiple myeloma therapy ( Prof Keith Stewart - Mayo Clinic, Scottsdale, USA )
6 Dec 2014
Overall survival update from the BREAK-3 study
Prof Axel Hauschild - University Hospital Schleswig-Holstein, Kiel, Germany
Overall survival update from the BREAK-3 study ( Prof Axel Hauschild - University Hospital Schleswig-Holstein, Kiel, Germany )
4 Dec 2014
A short tour of the p-medicine Ontology Annotator Tool
A short tour of the p-medicine Ontology Annotator Tool ( )
4 Dec 2014
A short tour of the p-medicine Custodix Anonymisation Tool
A short tour of the p-medicine Custodix Anonymisation Tool ( )
4 Dec 2014
A short tour of the p-medicine Workbench Tool
A short tour of the p-medicine Workbench Tool ( )
4 Dec 2014
A short tour of the p-medicine ALGA-C Questionnaire
A short tour of the p-medicine ALGA-C Questionnaire ( )
4 Dec 2014
A short tour of the p-medicine ALGA-C Profiler
A short tour of the p-medicine ALGA-C Profiler ( )
4 Dec 2014
Highlights of the EORTC-NCI-AACR Symposium
Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy
Highlights of the EORTC-NCI-AACR Symposium ( Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy )
2 Dec 2014

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation